Pancreatitis-Induced Inflammation Contributes to Pancreatic Cancer by Inhibiting Oncogene-Induced Senescence

Pancreatic Cancer

Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202

Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses

Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969

Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice

Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609

Pancreatic cancer

Hidalgo, M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0901557 · Cited by 2,570

Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse

Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471

Pancreatitis and the Risk of Pancreatic Cancer

Lowenfels, A. B., Maisonneuve, P., Cavallini, G., Ammann, R., Lankisch, P. G., Andersen, J. R., DiMagno, E. P., Andrén‐Sandberg, Å., & Domellöf, L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282001 · Cited by 1,753

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials

Rothwell, P. M., Fowkes, F. G. R., Belch, J. F., Ogawa, H., Warlow, C. P., & Meade, T. W. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62110-1 · Cited by 1,497

Senescence in premalignant tumours

Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482

Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice

Guerra, C., Schuhmacher, A. J., Cañamero, M., Grippo, P. J., Verdaguer, L., Pérez-Gallego, L., Dubus, P., Sandgren, E. P., & Barbacid, M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.01.012 · Cited by 1,224

Senescence in tumours: evidence from mice and humans

Collado, M., & Serrano, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2772 · Cited by 1,124 · cited 4×

Cell Intrinsic Role of COX-2 in Pancreatic Cancer Development

Hill, R., Li, Y., Tran, L. M., Dry, S., Calvopina, J. H., Garcia, A. J., Kim, C. G., Wang, Y., Donahue, T. R., Herschman, H. R., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0342 · Cited by 99

Senescent cancer-associated fibroblasts in pancreatic adenocarcinoma restrict CD8+ T cell activation and limit responsiveness to immunotherapy in mice

Assouline, B., Kahn, R., Hodali, L., Condiotti, R., Engel, Y., Elyada, E., Mordechay‐Heyn, T., Pitarresi, J. R., Atias, D., Steinberg, E., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50441-7 · Cited by 105

Cellular senescence in gastrointestinal diseases: from pathogenesis to therapeutics

Frey, N., Venturelli, S., Zender, L., & Bitzer, M. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.146 · Cited by 97

Cellular features of senescence during the evolution of human and murine ductal pancreatic cancer

Caldwell, M. E., DeNicola, G. M., Martins, C. P., Jacobetz, M. A., Maitra, A., Hruban, R. H., & Tuveson, D. A. (2011) · Oncogene · doi:10.1038/onc.2011.350 · Cited by 103

Extrinsic KRAS signaling shapes the pancreatic microenvironment through fibroblast reprogramming

Velez-Delgado, A., Donahue, K. L., Brown, K. L., Du, W., Irizarry-Negron, V., Menjivar, R. E., Lasse Opsahl, E. L., Steele, N. G., The, S., Lazarus, J., et al. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.02.016 · Cited by 91

The impact of hypoxia in pancreatic cancer invasion and metastasis

Díaz, B., & Yuen, A. (2014) · Hypoxia · doi:10.2147/hp.s52636 · Cited by 101

Risk factors for pancreatic cancer: underlying mechanisms and potential targets

Kolodecik, T. R., Shugrue, C., Ashat, M., & Thrower, E. C. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2013.00415 · Cited by 95

Physical activity and risk of pancreatic cancer: a systematic review and meta-analysis

Behrens, G., Jochem, C., Schmid, D., Keimling, M., Ricci, C., & Leitzmann, M. F. (2015) · European Journal of Epidemiology · doi:10.1007/s10654-015-0014-9 · Cited by 94

Senolytic elimination of Cox2-expressing senescent cells inhibits the growth of premalignant pancreatic lesions

Kolodkin‐Gal, D., Roitman, L., Ovadya, Y., Azazmeh, N., Assouline, B., Schlesinger, Y., Kalifa, R., Horwitz, S., Khalatnik, Y., Hochner-Ger, A., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-321112 · Cited by 93

The Emerging Role of Cyclin-Dependent Kinases (CDKs) in Pancreatic Ductal Adenocarcinoma

García-Reyes, B., Kretz, A.-L., Ruff, J.-P., von Karstedt, S., Hillenbrand, A., Knippschild, U., Henne‐Bruns, D., & Lemke, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103219 · Cited by 91

Growth Inhibitory Signaling of the Raf/MEK/ERK Pathway

Wu, P., Becker, A., & Park, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155436 · Cited by 93

Non-Cell-Autonomous Regulation of Cellular Senescence in Cancer

Mitri, D. D., & Alimonti, A. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.10.005 · Cited by 92

Cellular senescence in cancer: clinical detection and prognostic implications

Domen, A., Deben, C., Verswyvel, J., Flieswasser, T., Prenen, H., Peeters, M., Lardon, F., & Wouters, A. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02555-3 · Cited by 94

Translational research in oncology—10 years of progress and future prospects

Doroshow, J. H., & Kummar, S. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.158 · Cited by 91

Squamous trans-differentiation of pancreatic cancer cells promotes stromal inflammation

Somerville, T. D. D., Biffi, G., Daßler‐Plenker, J., Hur, S. K., He, X., Vance, K. E., Miyabayashi, K., Xu, Y., Maia-Silva, D., Klingbeil, O., et al. (2020) · eLife · doi:10.7554/elife.53381 · Cited by 87

CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma

Meng, F., Li, W., Li, C., GAO, Z., Guo, K., & Song, S. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2794 · Cited by 89

Kras and tumor immunity: friend or foe?

Cullis, J., Das, S., & Bar-Sagi, D. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031849 · Cited by 85

Cellular determinants and therapeutic implications of inflammation in pancreatic cancer

Stone, M. L., & Beatty, G. L. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.05.012 · Cited by 87

Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet

Luo, Y., Yang, Y., Liu, M., Wang, D., Wang, F., Bi, Y., Ji, J., Li, S., Liu, Y., Chen, R., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.07.030 · Cited by 87

Surgery for chronic pancreatitis decreases the risk for pancreatic cancer: A multicenter retrospective analysis

Ueda, J., Tanaka, M., Ohtsuka, T., Tokunaga, S., & Shimosegawa, T. (2012) · Surgery · doi:10.1016/j.surg.2012.08.005 · Cited by 87

Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes

Zhao, L., Zhao, H., & Yan, H. (2018) · BMC Cancer · doi:10.1186/s12885-018-4546-8 · Cited by 93

The role of inflammatory cells in fostering pancreatic cancer cell growth and invasion

Costello, E. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00270 · Cited by 84

Prognostic Value of the Systemic Immune-Inflammation Index (SII) After Neoadjuvant Therapy for Patients with Resected Pancreatic Cancer

Murthy, P., Zenati, M. S., Abbas, A. I. A., Rieser, C. J., Bahary, N., Lotze, M. T., Zeh, H. J., Zureikat, A. H., & Boone, B. A. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-08094-0 · Cited by 85

International consensus guidelines on surveillance for pancreatic cancer in chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and European Pancreatic Club

Greenhalf, W., Lévy, P., Gress, T. M., Rebours, V., Brand, R. E., Pandol, S., Chari, S. T., Jørgensen, M. T., Mayerle, J. V., Lerch, M. M., et al. (2020) · Pancreatology · doi:10.1016/j.pan.2020.05.011 · Cited by 83

Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer

McIntyre, C. A., Grimont, A., Park, J., Meng, Y., Sisso, W. J., Seier, K. P., Jang, G. H., Walch, H. S., Aveson, V. G., Falvo, D. J., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.08.002 · Cited by 85

Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment

Ren, C., Cheng, X., Lü, B., & Yang, G. S. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.07.140 · Cited by 83

Implication of PI3K/Akt pathway in pancreatic cancer: When PI3K isoforms matter?

Baer, R., Cintas, C., Therville, N., & Guillermet‐Guibert, J. (2015) · Advances in Biological Regulation · doi:10.1016/j.jbior.2015.05.001 · Cited by 85

Phosphorylation of Ribosomal Protein S6 Attenuates DNA Damage and Tumor Suppression during Development of Pancreatic Cancer

Khalaileh, A., Dreazen, A., Khatib, A., Apel, R., Swisa, A., Kidess-Bassir, N., Maitra, A., Meyuhas, O., Dor, Y., & Zamir, G. A. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2014 · Cited by 84

RAS in pancreatic cancer

Lanfredini, S., Thapa, A., & O’Neill, E. E. (2019) · Biochemical Society Transactions · doi:10.1042/bst20170521 · Cited by 78

Senescence-associated SIN3B promotes inflammation and pancreatic cancer progression

Rielland, M., Cantor, D. J., Graveline, R., Hajdu, C., Mara, L., de Diego Diaz, B., Miller, G., & David, G. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72619 · Cited by 76

In vivo reprogramming drives Kras-induced cancer development

Shibata, H., Komura, S., Yamada, Y., Sankoda, N., Tanaka, A., Ukai, T., Kabata, M., Sakurai, S., Kuze, B., Woltjen, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04449-5 · Cited by 76

IL-20 antagonist suppresses PD-L1 expression and prolongs survival in pancreatic cancer models

Lu, S.-W., Pan, H.-C., Hsu, Y., Chang, K., Wu, L., Chen, W., & Chang, M. (2020) · Nature Communications · doi:10.1038/s41467-020-18244-8 · Cited by 76

Tumor-Stromal Interactions in Pancreatic Cancer

Whatcott, C. J., Han, H., Posner, R. G., & Hoff, D. D. V. (2012) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v18.i1-2.80 · Cited by 80

Current Knowledge on Pancreatic Cancer

Iovanna, J., Mallmann, M. C., Gonçalvès, A., Turrini, O., & Dagorn, J. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00006 · Cited by 74

A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma—A Proof of Antigen Discovery Feasibility in Three Patients

Bassani‐Sternberg, M., Digklia, A., Huber, F., Wagner, D., Sempoux, C. L., Stevenson, B. J., Thierry, A., Michaux, J., Pak, H., Racle, J., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01832 · Cited by 75

Perfluorooctanoic acid exposure triggers oxidative stress in the mouse pancreas

Kamendulis, L. M., Wu, Q., Sandusky, G. E., & Hocevar, B. A. (2014) · Toxicology Reports · doi:10.1016/j.toxrep.2014.07.015 · Cited by 73

THZ1 reveals CDK7-dependent transcriptional addictions in pancreatic cancer

Lu, P., Geng, J., Zhang, L., Wang, Y., Niu, N., Fang, Y., Liu, F., Shi, J., Zhang, Z., Sun, Y., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0701-1 · Cited by 71

CXCL10/CXCR3 signaling contributes to an inflammatory microenvironment and its blockade enhances progression of murine pancreatic precancerous lesions

Pandey, V., Martinez, A. K. F., Bastea, L. I., Döppler, H. R., Eisenhauer, J., Le, T., Edenfield, B. H., & Störz, P. (2021) · eLife · doi:10.7554/elife.60646 · Cited by 73

Splicing Factor SRSF1 Promotes Pancreatitis and KRASG12D-Mediated Pancreatic Cancer

Wan, L., Lin, K., Rahman, M. A., Ishigami, Y., Wang, Z., Jensen, M. A., Wilkinson, J. E., Park, Y., Tuveson, D. A., & Krainer, A. R. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-1013 · Cited by 72

Inflammation in thyroid oncogenesis.

Liotti, F., Visciano, C., & Melillo, R. M. (2012) · Europe PMC (PubMed Central) · Cited by 73

Activation of TLR4 Is Required for the Synergistic Induction of Dual Oxidase 2 and Dual Oxidase A2 by IFN-γ and Lipopolysaccharide in Human Pancreatic Cancer Cell Lines

Wu, Y., Lu, J., Antony, S., Juhasz, A. N., Liu, H., Jiang, G., Meitzler, J. L., Hollingshead, M. G., Haines, D. C., Butcher, D. O., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201725 · Cited by 73

Targeting Plk1 Sensitizes Pancreatic Cancer to Immune Checkpoint Therapy

Zhang, Z., Cheng, L., Li, J., Qiao, Q., Karki, A., Allison, D. B., Shaker, N., Li, K., Utturkar, S. M., Lanman, N. A., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-0018 · Cited by 70

Signaling Networks That Control Cellular Plasticity in Pancreatic Tumorigenesis, Progression, and Metastasis

Crawford, H. C., di Magliano, M. P., & Banerjee, S. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.12.042 · Cited by 73

Pancreatic Cancer in Chronic Pancreatitis: Pathogenesis and Diagnostic Approach

Cosquer, G. L., Maulat, C., Bournet, B., Cordelier, P., Buscail, É., & Buscail, L. (2023) · Cancers · doi:10.3390/cancers15030761 · Cited by 73

The Fire within: Cell-Autonomous Mechanisms in Inflammation-Driven Cancer

Todoric, J., & Karin, M. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.04.001 · Cited by 69

A reversible epigenetic memory of inflammatory injury controls lineage plasticity and tumor initiation in the mouse pancreas

Falvo, D. J., Grimont, A., Zumbo, P., Fall, W. B., Yang, J. L., Osterhoudt, A., Pan, G., Rendeiro, A. F., Meng, Y., Wilkinson, J. E., et al. (2023) · Developmental Cell · doi:10.1016/j.devcel.2023.11.008 · Cited by 65

CDKN2B deletion is essential for pancreatic cancer development instead of unmeaningful co-deletion due to juxtaposition to CDKN2A

Tu, Q., Hao, J., Zhou, X., Yan, L., Dai, H., Sun, B., Yang, D., An, S., Lv, L., Jiao, B., et al. (2018) · Oncogene · doi:10.1038/onc.2017.316 · Cited by 66

Pancreatic Cancer Metastasis: Are we being Pre-EMTed?

Das, S., & Batra, S. K. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666141211115234 · Cited by 65

Deploying Immunotherapy in Pancreatic Cancer: Defining Mechanisms of Response and Resistance

Beatty, G. L., Eghbali, S. Z., & Kim, R. (2017) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_175232 · Cited by 64

Epithelial to Mesenchymal Transition: Key Regulator of Pancreatic Ductal Adenocarcinoma Progression and Chemoresistance

Palamaris, K., Felekouras, E. S., & Sakellariou, S. (2021) · Cancers · doi:10.3390/cancers13215532 · Cited by 70

Analysis of the tumor-initiating and metastatic capacity of PDX1-positive cells from the adult pancreas

Ischenko, I., Petrenko, O., & Hayman, M. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319911111 · Cited by 62

Dexamethasone mediates pancreatic cancer progression by glucocorticoid receptor, TGFβ and JNK/AP-1

Liu, L., Aleksandrowicz, E., Schönsiegel, F., Groener, D., Bauer, N., Nwaeburu, C. C., Zhao, Z., Gladkich, J., Hoppe‐Tichy, T., Yefenof, E., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.455 · Cited by 63

Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells

Lee, J., Snyder, E. R., Liu, Y., Gu, X., Wang, J., Flowers, B. M., Kim, Y. J., Park, S., Szot, G. L., Hruban, R. H., et al. (2017) · Nature Communications · doi:10.1038/ncomms14686 · Cited by 64

Deciphering DNA methylation signatures of pancreatic cancer and pancreatitis

Natale, F., Vivo, M., Falco, G., & Angrisano, T. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0728-8 · Cited by 64

Inflammation and Hras signaling control epithelial–mesenchymal transition during skin tumor progressionPreprint

Wong, C. E., Yu, J. S., Quigley, D. A., To, M. D., Jen, K., Huang, P., Rosario, R. D., & Balmain, A. (2013) · Genes & Development · doi:10.1101/gad.210427.112 · Cited by 62

Pancreatic Cancer and Cellular Senescence: Tumor Microenvironment under the Spotlight

Cortesi, M., Zanoni, M., Pirini, F., Tumedei, M. M., Ravaioli, S., Rapposelli, I. G., Frassineti, G. L., & Bravaccini, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010254 · Cited by 62

Preclinical Models of Pancreatic Ductal Adenocarcinoma and Their Utility in Immunotherapy Studies

Pham, T. D., Shields, M. A., Spaulding, C., Principe, D. R., Li, B., Underwood, P. W., Trevino, J. G., Bentrem, D. J., & Munshi, H. G. (2021) · Cancers · doi:10.3390/cancers13030440 · Cited by 64

Autophagy in pancreatic cancer pathogenesis and treatment.

Kang, R., & Tang, D. (2012) · Europe PMC (PubMed Central) · Cited by 60

TGF-β1 promotes acinar to ductal metaplasia of human pancreatic acinar cells

Liu, J., Akanuma, N., Liu, C., Naji, A., Halff, G. A., Washburn, W. K., Sun, L., & Wang, P. (2016) · Scientific Reports · doi:10.1038/srep30904 · Cited by 60

Dynamic landscape of pancreatic carcinogenesis reveals early molecular networks of malignancy

Kong, B., Bruns, P., Behler, N., Chang, L., Schlitter, A. M., Cao, J., Gewies, A., Ruland, J., Fritzsche, S., Valkovskaya, N., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310913 · Cited by 64

HPV associated tumor cells control tumor microenvironment and leukocytosis in experimental models

Stone, S. C., Rossetti, R. A. M., Lima, A. M., & Lepique, A. P. (2014) · Immunity Inflammation and Disease · doi:10.1002/iid3.21 · Cited by 59

Live Imaging and Gene Expression Analysis in Zebrafish Identifies a Link between Neutrophils and Epithelial to Mesenchymal Transition

Freisinger, C. M., & Huttenlocher, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112183 · Cited by 59

Blocking VCAM-1 inhibits pancreatic tumour progression and cancer-associated thrombosis/thromboembolism

Sano, M., Takahashi, R., Ijichi, H., Ishigaki, K., Yamada, T., Miyabayashi, K., Kimura, G., Mizuno, S., Kato, H., Fujiwara, H., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-320608 · Cited by 56

The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells

Fu, Y., Ricciardiello, F., Yang, G., Qiu, J., Huang, H., Xiao, J., Cao, Z., Zhao, F., Liu, Y., Luo, W., et al. (2021) · Cells · doi:10.3390/cells10030497 · Cited by 59

Uncertain Beginnings: Acinar and Ductal Cell Plasticity in the Development of Pancreatic Cancer

Grimont, A., Leach, S. D., & Chandwani, R. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.07.014 · Cited by 64

PLAC8 Localizes to the Inner Plasma Membrane of Pancreatic Cancer Cells and Regulates Cell Growth and Disease Progression through Critical Cell-Cycle Regulatory Pathways

Kaistha, B. P., Lorenz, H., Schmidt, H., Sipos, B., Pawlak, M., Gierke, B., Kreider, R., Lankat–Buttgereit, B., Sauer, M., Fiedler, L., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0216 · Cited by 58

ERK1/2 Signaling Induces Upregulation of ANGPT2 and CXCR4 to Mediate Liver Metastasis in Colon Cancer

Urosevic, J., Blasco, M. T., Lope, A. L., Bellmunt, A., Berenguer, A., Guiu, M., Cañellas-Socias, A., Fernández, E., Burkov, I., Clapés, M., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-4028 · Cited by 56

The role of epithelial-mesenchymal transition and autophagy in pancreatic ductal adenocarcinoma invasion

Yang, J. Z., Liu, Y., & Liu, S. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06032-3 · Cited by 61

Transcriptome analysis of pancreatic cancer reveals a tumor suppressor function for HNF1A

Hoskins, J. W., Jia, J., Flández, M., Parikh, H. M., Xiao, W., Collins, I. J., Emmanuel, M. A., Ibrahim, A. M., Powell, J. I., Zhang, L., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu193 · Cited by 54

Aberrant over-expression of TRPM7 ion channels in pancreatic cancer: required for cancer cell invasion and implicated in tumor growth and metastasis

Yee, N. S., Kazi, A. A., Li, Q., Yang, Z., Berg, A. S., & Yee, R. K. (2015) · Biology Open · doi:10.1242/bio.20137088 · Cited by 54

Overcoming immunotherapeutic resistance by targeting the cancer inflammation cycle

Wattenberg, M. M., & Beatty, G. L. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.01.002 · Cited by 54

Multifaceted role for p53 in pancreatic cancer suppression

Mello, S. S., Flowers, B. M., Mazur, P. K., Lee, J. J., Müller, F., Denny, S. K., Ferreira, S., Hanson, K., Kim, S. K., Greenleaf, W. J., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211937120 · Cited by 55

Circumventing senescence is associated with stem cell properties and metformin sensitivity

Deschênes‐Simard, X., Parisotto, M., Rowell, M., Le Calvé, B., Igelmann, S., Moineau‐Vallée, K., Saint‐Germain, E., Kalegari, P., Bourdeau, V., Kottakis, F., et al. (2019) · Aging Cell · doi:10.1111/acel.12889 · Cited by 45

Genetic inactivation of the pancreatitis-inducible gene Nupr1 impairs PanIN formation by modulating KrasG12D-induced senescence

Grasso, D., Garcia, M. N., Hamidi, T., Cano, C. E., Calvo, E. L., Lomberk, G. A., Urrutia, R. A., & Iovanna, J. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.74 · Cited by 53

A genetic roadmap of pancreatic cancer: still evolving

Notta, F., Hahn, S. A., & Real, F. X. (2017) · Gut · doi:10.1136/gutjnl-2016-313317 · Cited by 54

40 Years of RAS—A Historic Overview

Fernández‐Medarde, A., Rivas, J. D. L., & Santos, E. (2021) · Genes · doi:10.3390/genes12050681 · Cited by 57

TREM2 Depletion in Pancreatic Cancer Elicits Pathogenic Inflammation and Accelerates Tumor Progression via Enriching IL-1β+ Macrophages

Yang, D., Sun, X., Wang, H., Wistuba, I. I., Wang, H., Maitra, A., & Chen, Y. (2025) · Gastroenterology · doi:10.1053/j.gastro.2025.01.244 · Cited by 56

Ubiquitin-specific protease 22-induced autophagy is correlated with poor prognosis of pancreatic cancer

Liang, J., Ning, Z., Gao, W., Ling, J., Wang, A., Luo, H., Liang, Y., Yan, Q., & Wang, Z. (2014) · Oncology Reports · doi:10.3892/or.2014.3508 · Cited by 50

The Transcription Factor GLI1 Modulates the Inflammatory Response during Pancreatic Tissue Remodeling

Mathew, E., Collins, M. A., Fernández‐Barrena, M. G., Holtz, A. M., Yan, W., Hogan, J. O., Tata, Z., Allen, B. L., Fernández-Zapico, M. E., & di Magliano, M. P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.556563 · Cited by 52

Obesity, autophagy and the pathogenesis of liver and pancreatic cancers

Aghajan, M., Li, N., & Karin, M. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.07008.x · Cited by 48

Inflammation and pancreatic cancer: disease promoter and new therapeutic target

Hamada, S., Masamune, A., & Shimosegawa, T. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0915-x · Cited by 50

Epithelial-Stromal Interactions in Pancreatic Cancer

Zhang, Y., Crawford, H. C., & di Magliano, M. P. (2018) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114515 · Cited by 52

miR-802 Suppresses Acinar-to-Ductal Reprogramming During Early Pancreatitis and Pancreatic Carcinogenesis

Ge, W., Goga, A., He, Y., Silva, P. N., Hirt, C., Herrmanns, K., Guccini, I., Godbersen, S., Schwank, G., & Stoffel, M. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.09.029 · Cited by 48

Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis

Martínez‐Bosch, N., Cristóbal, H., Iglesias, M., Gironella, M., Barranco, L., Visa, L., Calafato, D., Jiménez-Parrado, S., Earl, J., Carrato, A., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103797 · Cited by 48

Interaction between pancreatic cancer cells and tumor‐associated macrophages promotes the invasion of pancreatic cancer cells and the differentiation and migration of macrophages

Meng, F., Li, C., Wan, L., Gao, Z., Guo, K., & Song, S. (2014) · IUBMB Life · doi:10.1002/iub.1336 · Cited by 47

Hedgehog Signaling Non-Canonical Activated by Pro-Inflammatory Cytokines in Pancreatic Ductal Adenocarcinoma

Wang, Y., Jin, G., Li, Q., Wang, Z., Hu, W., Li, P., Li, S.-D., Wu, H., Kong, X., Gao, J., et al. (2016) · Journal of Cancer · doi:10.7150/jca.15786 · Cited by 47

NF-κB/Rel Transcription Factors in Pancreatic Cancer: Focusing on RelA, c-Rel, and RelB

Kabacaoğlu, D., Ruess, D. A., Ai, J., & Algül, H. (2019) · Cancers · doi:10.3390/cancers11070937 · Cited by 49

Ras signaling is essential for skin development

Drosten, M., Lechuga, C. G., & Barbacid, M. (2014) · Oncogene · doi:10.1038/onc.2013.254 · Cited by 46

Oxidative Stress Induced by Inactivation of TP53INP1 Cooperates with KrasG12D to Initiate and Promote Pancreatic Carcinogenesis in the Murine Pancreas

Saati, T. A., Clerc, P., Hanoun, N., Peuget, S., Lulka, H., Gigoux, V., Capilla, F., Béluchon, B., Couvelard, A., Sèlves, J., et al. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.02.034 · Cited by 46

Functional activity and tumor-specific expression of dual oxidase 2 in pancreatic cancer cells and human malignancies characterized with a novel monoclonal antibody

WU, Y., Antony, S., Hewitt, S. M., Jiang, G., Yang, S. X., Meitzler, J. L., Juhasz, A. N., Lu, J., Liu, H., Doroshow, J. H., et al. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1821 · Cited by 46

Stomach-Specific Activation of Oncogenic KRAS and STAT3-Dependent Inflammation Cooperatively Promote Gastric Tumorigenesis in a Preclinical Model

Thiem, S., Eissmann, M. F., Elzer, J., Jonas, A., Putoczki, T. L., Poh, A. R., Nguyen, P. M., Preaudet, A., Flanagan, D. J., Vincan, E., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3089 · Cited by 45

Pancreatic cancer: molecular pathogenesis and emerging therapeutic strategies

Rozengurt, E., & Eibl, G. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02499-y · Cited by 49

Discovering the route from inflammation to pancreatic cancer.

Momi, N., Kaur, S., Krishn, S. R., & Batra, S. K. (2012) · PubMed · Cited by 44

GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression

Baumgart, S., Chen, N., Zhang, J., Billadeau, D. D., Gaisina, I. N., Kozikowski, A. P., Singh, S. K., Fink, D., Ströbel, P., Klindt, C., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0309 · Cited by 44

Kras mutation rate precisely orchestrates ductal derived pancreatic intraepithelial neoplasia and pancreatic cancer

Singh, K., Pruski, M. A., Bland, R., Younes, M., Guha, S., Thosani, N. C., Maitra, A., Cash, B. D., McAllister, F. M., Logsdon, C. D., et al. (2020) · Laboratory Investigation · doi:10.1038/s41374-020-00490-5 · Cited by 43

NFATc4 Regulates Sox9 Gene Expression in Acinar Cell Plasticity and Pancreatic Cancer Initiation

Heßmann, E., Zhang, J., Chen, N., Hasselluhn, M. C., Liou, G., Störz, P., Ellenrieder, V., Billadeau, D. D., & König, A. O. (2015) · Stem Cells International · doi:10.1155/2016/5272498 · Cited by 43

KrasandLkb1mutations synergistically induce intraductal papillary mucinous neoplasm derived from pancreatic duct cells

Collet, L., Ghurburrun, E., Meyers, N., Assi, M., Pirlot, B., Leclercq, I. A., Couvelard, A., Komuta, M., Cros, J. F., Demetter, P., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-318059 · Cited by 43

Novel therapeutic strategies and perspectives for metastatic pancreatic cancer: vaccine therapy is more than just a theory

Luo, W., Yang, G., Luo, W., Cao, Z., Liu, Y., Qiu, J., Chen, G., You, L., Zhao, F., Zheng, L., et al. (2020) · Cancer Cell International · doi:10.1186/s12935-020-1147-9 · Cited by 41

Ductal vs. acinar? Recent insights into identifying cell lineage of pancreatic ductal adenocarcinoma

Xu, Y., Liu, J., Nipper, M. H., & Wang, P. (2019) · Annals of Pancreatic Cancer · doi:10.21037/apc.2019.06.03 · Cited by 39

Endogenous glutamine decrease is associated with pancreatic cancer progression

Roux, C., Riganti, C., Borgogno, S. F., Curto, R., Curcio, C., Catanzaro, V., Digilio, G., Padovan, S., Puccinelli, M. P., Isabello, M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20545 · Cited by 40

Highlights from Recent Cancer Literature

(2011) · Cancer Research · doi:10.1158/0008-5472.5363.71.16

Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic Kras

Carrière, C., Young, A. L., Gunn, J. R., Longnecker, D. S., & Korc, M. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.03.068 · Cited by 236

Pancreatitis promotes oncogenic KrasG12D-induced pancreatic transformation through activation of Nupr1

Grasso, D., Garcia, M. N., Hamidi, T., Cano, C. E., Calvo, E. L., Lomberk, G. A., Urrutia, R. A., & Iovanna, J. (2014) · Molecular & Cellular Oncology · doi:10.4161/mco.29913 · Cited by 4

Induction of Pancreatic Inflammation Accelerates Pancreatic Tumorigenesis in Mice

Zhuang, L., Zhan, X., Bi, Y., & Ji, B. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8879-2_25 · Cited by 5

Acute Pancreatitis Accelerates Initiation and Progression to Pancreatic Cancer in Mice Expressing Oncogenic Kras

Lineage, I. T. N. C. (2011)